BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11080212)

  • 1. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
    Double KL; Zecca L; Costi P; Mauer M; Griesinger C; Ito S; Ben-Shachar D; Bringmann G; Fariello RG; Riederer P; Gerlach M
    J Neurochem; 2000 Dec; 75(6):2583-9. PubMed ID: 11080212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyldopamine is not incorporated into neuromelanin.
    Wakamatsu K; Ito S; Nagatsu T
    Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of neuromelanin as studied by chemical degradative methods.
    Wakamatsu K; Fujikawa K; Zucca FA; Zecca L; Ito S
    J Neurochem; 2003 Aug; 86(4):1015-23. PubMed ID: 12887698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuromelanin of the human substantia nigra.
    Carstam R; Brinck C; Hindemith-Augustsson A; Rorsman H; Rosengren E
    Biochim Biophys Acta; 1991 Sep; 1097(2):152-60. PubMed ID: 1911888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.
    Aime S; Bergamasco B; Casu M; Digilio G; Fasano M; Giraudo S; Lopiano L
    Mov Disord; 2000 Sep; 15(5):977-81. PubMed ID: 11009208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromelanin of the human substantia nigra: a mixed-type melanin.
    Odh G; Carstam R; Paulson J; Wittbjer A; Rosengren E; Rorsman H
    J Neurochem; 1994 May; 62(5):2030-6. PubMed ID: 8158151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-binding characteristics of neuromelanin of the human substantia nigra.
    Double KL; Gerlach M; Schünemann V; Trautwein AX; Zecca L; Gallorini M; Youdim MB; Riederer P; Ben-Shachar D
    Biochem Pharmacol; 2003 Aug; 66(3):489-94. PubMed ID: 12907248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
    Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Wilczok T; Arzberger T; Riederer P; Gerlach M
    J Am Soc Mass Spectrom; 2004 Jun; 15(6):920-6. PubMed ID: 15144983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS; Nilges MJ; Swartz HM
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromelanin of the human substantia nigra: an update.
    Zucca FA; Basso E; Cupaioli FA; Ferrari E; Sulzer D; Casella L; Zecca L
    Neurotox Res; 2014 Jan; 25(1):13-23. PubMed ID: 24155156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human substantia nigra neuromelanin with lipids and peptides.
    Zecca L; Costi P; Mecacci C; Ito S; Terreni M; Sonnino S
    J Neurochem; 2000 Apr; 74(4):1758-65. PubMed ID: 10737635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
    Zecca L; Shima T; Stroppolo A; Goj C; Battiston GA; Gerbasi R; Sarna T; Swartz HM
    Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.
    Shima T; Sarna T; Swartz HM; Stroppolo A; Gerbasi R; Zecca L
    Free Radic Biol Med; 1997; 23(1):110-9. PubMed ID: 9165303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus.
    Wakamatsu K; Tabuchi K; Ojika M; Zucca FA; Zecca L; Ito S
    J Neurochem; 2015 Nov; 135(4):768-76. PubMed ID: 26156066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D
    Ito H; Kawaguchi H; Kodaka F; Takuwa H; Ikoma Y; Shimada H; Kimura Y; Seki C; Kubo H; Ishii S; Takano H; Suhara T
    Neuroimage; 2017 Sep; 158():12-17. PubMed ID: 28655632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.
    Gerlach M; Trautwein AX; Zecca L; Youdim MB; Riederer P
    J Neurochem; 1995 Aug; 65(2):923-6. PubMed ID: 7616255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometry.
    Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Riederer P; Gerlach M
    J Neural Transm (Vienna); 2006 Jun; 113(6):729-34. PubMed ID: 16755376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemical characterization of melanin contained in substantia nigra of human brain.
    Zecca L; Mecacci C; Seraglia R; Parati E
    Biochim Biophys Acta; 1992 Jan; 1138(1):6-10. PubMed ID: 1737070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dolichol is the major lipid component of human substantia nigra neuromelanin.
    Fedorow H; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B
    J Neurochem; 2005 Feb; 92(4):990-5. PubMed ID: 15686500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra.
    Aime S; Fasano M; Bergamasco B; Lopiano L; Valente G
    J Neurochem; 1994 Jan; 62(1):369-71. PubMed ID: 8263538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.